Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17549691rdf:typepubmed:Citationlld:pubmed
pubmed-article:17549691lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:17549691lifeskim:mentionsumls-concept:C0596790lld:lifeskim
pubmed-article:17549691lifeskim:mentionsumls-concept:C0006098lld:lifeskim
pubmed-article:17549691lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:17549691lifeskim:mentionsumls-concept:C1273604lld:lifeskim
pubmed-article:17549691lifeskim:mentionsumls-concept:C0332332lld:lifeskim
pubmed-article:17549691lifeskim:mentionsumls-concept:C0205355lld:lifeskim
pubmed-article:17549691pubmed:issue2lld:pubmed
pubmed-article:17549691pubmed:dateCreated2007-7-9lld:pubmed
pubmed-article:17549691pubmed:abstractTextThe impact of primary Gleason pattern was determined on cause-specific (CSS), biochemical progression-free (bPFS), and overall survival (OS) after brachytherapy for Gleason score 7 prostate cancer.lld:pubmed
pubmed-article:17549691pubmed:languageenglld:pubmed
pubmed-article:17549691pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17549691pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17549691pubmed:statusMEDLINElld:pubmed
pubmed-article:17549691pubmed:monthJullld:pubmed
pubmed-article:17549691pubmed:issn0008-543Xlld:pubmed
pubmed-article:17549691pubmed:authorpubmed-author:MerrickGregor...lld:pubmed
pubmed-article:17549691pubmed:authorpubmed-author:ButlerWayne...lld:pubmed
pubmed-article:17549691pubmed:authorpubmed-author:GalbreathRobe...lld:pubmed
pubmed-article:17549691pubmed:authorpubmed-author:AdamovichEdwa...lld:pubmed
pubmed-article:17549691pubmed:authorpubmed-author:AllenZacharia...lld:pubmed
pubmed-article:17549691pubmed:authorpubmed-author:LiefJonathanJlld:pubmed
pubmed-article:17549691pubmed:authorpubmed-author:WallerKent...lld:pubmed
pubmed-article:17549691pubmed:issnTypePrintlld:pubmed
pubmed-article:17549691pubmed:day15lld:pubmed
pubmed-article:17549691pubmed:volume110lld:pubmed
pubmed-article:17549691pubmed:ownerNLMlld:pubmed
pubmed-article:17549691pubmed:authorsCompleteYlld:pubmed
pubmed-article:17549691pubmed:pagination289-96lld:pubmed
pubmed-article:17549691pubmed:meshHeadingpubmed-meshheading:17549691...lld:pubmed
pubmed-article:17549691pubmed:meshHeadingpubmed-meshheading:17549691...lld:pubmed
pubmed-article:17549691pubmed:meshHeadingpubmed-meshheading:17549691...lld:pubmed
pubmed-article:17549691pubmed:meshHeadingpubmed-meshheading:17549691...lld:pubmed
pubmed-article:17549691pubmed:meshHeadingpubmed-meshheading:17549691...lld:pubmed
pubmed-article:17549691pubmed:meshHeadingpubmed-meshheading:17549691...lld:pubmed
pubmed-article:17549691pubmed:meshHeadingpubmed-meshheading:17549691...lld:pubmed
pubmed-article:17549691pubmed:meshHeadingpubmed-meshheading:17549691...lld:pubmed
pubmed-article:17549691pubmed:year2007lld:pubmed
pubmed-article:17549691pubmed:articleTitlePrimary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer.lld:pubmed
pubmed-article:17549691pubmed:affiliationSchiffler Cancer Center, Wheeling, West Virginia 26003-6300, USA. gmerrick@urologicresearchinstitute.orglld:pubmed
pubmed-article:17549691pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17549691lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17549691lld:pubmed